The Antibacterial Capabilities of Alginate Encapsulated Lemon Essential Oil Nanocapsules Against Multi-drug-resistant Acinetobacter Baumannii

Overview

Journal Sci Rep

Date 2025 Jan 11

PMID 39799196

Authors

Fatemeh-Sadat Gholamhossein Tabar Valookolaei

Hossein Sazegar

Leila Rouhi

Affiliations

Soon will be listed here.

Abstract

Controlling microbial pollutants is a significant public health concern as they cause several chronic microbial infections and illnesses. In recent years, essential oils (EOs) have become intriguing alternatives for synthetic antimicrobials due to their biodegradability, natural source extraction, and strong antibacterial properties. The bactericidal properties of alginate containing lemon essential oil were examined in this investigation. Following the screening of the MDR strains, the morphological properties of the produced nanoparticles were examined using SEM, DLS, and FTIR. Additionally, the durability, effectiveness, and drug dispersion of encapsulation were assessed. Bacterial virulence factor gene amounts were measured using Q-real-time PCR. Concurrently, the cytotoxic effect of the nanomaterials was evaluated using MTT techniques. Nanoparticles of lemon essential oil encapsulated in alginate, measuring 500 ± 19.32 nm in size, with entrapment efficiency of 77.73 ± 1.78% and were stable for 60 days at 4 °C. Alginate encapsulated with lemon essential oil nanoparticles (ALN) exhibited potent antibacterial qualities, according to the biological investigation. Their ability to decrease the transcription of bacterial virulence genes at least statistically significantly (P ≤ 0.05) served as evidence for this. Between 1.56 and 100 µg/mL (P ≤ 0.01), ALN exhibited lower cytotoxicity against CCD841CoN than free lemon essential oil. The findings show that ALN nanoparticles have the potential to be a breakthrough in the fight against highly resistant illnesses. ALN nanoparticles' potent antibacterial efficacy against MDR strains of Acinetobacter baumannii may inspire new directions in antibacterial research.

References

McNeilly O, Mann R, Hamidian M, Gunawan C . Emerging Concern for Silver Nanoparticle Resistance in and Other Bacteria. Front Microbiol. 2021; 12:652863. PMC: 8085274. DOI: 10.3389/fmicb.2021.652863. View

Ahmad Raus R, Wan Nawawi W, Nasaruddin R . Alginate and alginate composites for biomedical applications. Asian J Pharm Sci. 2021; 16(3):280-306. PMC: 8261255. DOI: 10.1016/j.ajps.2020.10.001. View

Valookolaei F, Sazegar H, Rouhi L . Limonene encapsulated alginate/collagen as antibiofilm drug against Acinetobacter baumannii. BMC Biotechnol. 2024; 24(1):86. PMC: 11531196. DOI: 10.1186/s12896-024-00888-9. View

Shaker M, Shaaban M . Synthesis of silver nanoparticles with antimicrobial and anti-adherence activities against multidrug-resistant isolates from . J Taibah Univ Med Sci. 2019; 12(4):291-297. PMC: 6694881. DOI: 10.1016/j.jtumed.2017.02.008. View

Murugaiyan J, Kumar P, Rao G, Iskandar K, Hawser S, Hays J . Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. Antibiotics (Basel). 2022; 11(2). PMC: 8868457. DOI: 10.3390/antibiotics11020200. View

Liu W, Golshan N, Deng X, Hickey D, Zeimer K, Li H . Selenium nanoparticles incorporated into titania nanotubes inhibit bacterial growth and macrophage proliferation. Nanoscale. 2016; 8(34):15783-94. DOI: 10.1039/c6nr04461a. View

Panda S, Buroni S, Swain S, Bonacorsi A, Amorim E, Kulshrestha M . Recent advances to combat ESKAPE pathogens with special reference to essential oils. Front Microbiol. 2022; 13:1029098. PMC: 9763703. DOI: 10.3389/fmicb.2022.1029098. View

Brooks B, Brooks A . Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev. 2014; 78:14-27. DOI: 10.1016/j.addr.2014.10.027. View

Ballen V, Gabasa Y, Ratia C, Sanchez M, Soto S . Correlation Between Antimicrobial Resistance, Virulence Determinants and Biofilm Formation Ability Among Extraintestinal Pathogenic Strains Isolated in Catalonia, Spain. Front Microbiol. 2022; 12:803862. PMC: 8786794. DOI: 10.3389/fmicb.2021.803862. View

10.

da Cunha B, Fonseca L, Calado C . Antibiotic Discovery: Where Have We Come from, Where Do We Go?. Antibiotics (Basel). 2019; 8(2). PMC: 6627412. DOI: 10.3390/antibiotics8020045. View

11.

Pompilio A, Scribano D, Sarshar M, Di Bonaventura G, Palamara A, Ambrosi C . Gram-Negative Bacteria Holding Together in a Biofilm: The Way. Microorganisms. 2021; 9(7). PMC: 8304980. DOI: 10.3390/microorganisms9071353. View

12.

Liakos I, Rizzello L, Scurr D, Pompa P, Bayer I, Athanassiou A . All-natural composite wound dressing films of essential oils encapsulated in sodium alginate with antimicrobial properties. Int J Pharm. 2013; 463(2):137-45. DOI: 10.1016/j.ijpharm.2013.10.046. View

13.

Roy S, Chowdhury G, Mukhopadhyay A, Dutta S, Basu S . Convergence of Biofilm Formation and Antibiotic Resistance in Infection. Front Med (Lausanne). 2022; 9:793615. PMC: 8987773. DOI: 10.3389/fmed.2022.793615. View

14.

Beceiro A, Tomas M, Bou G . Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev. 2013; 26(2):185-230. PMC: 3623377. DOI: 10.1128/CMR.00059-12. View

15.

Severino P, da Silva C, Andrade L, de Lima Oliveira D, Campos J, Souto E . Alginate Nanoparticles for Drug Delivery and Targeting. Curr Pharm Des. 2019; 25(11):1312-1334. DOI: 10.2174/1381612825666190425163424. View

16.

Mi G, Shi D, Wang M, Webster T . Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces. Adv Healthc Mater. 2018; 7(13):e1800103. DOI: 10.1002/adhm.201800103. View

17.

Cheow W, Hadinoto K . Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces. 2011; 85(2):214-20. DOI: 10.1016/j.colsurfb.2011.02.033. View

18.

Amorim J, Simas D, Pinheiro M, Moreno D, Alviano C, Silva A . Anti-Inflammatory Properties and Chemical Characterization of the Essential Oils of Four Citrus Species. PLoS One. 2016; 11(4):e0153643. PMC: 4835072. DOI: 10.1371/journal.pone.0153643. View

19.

Kasza K, Gurnani P, Hardie K, Camara M, Alexander C . Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue account. Adv Drug Deliv Rev. 2021; 178:113973. DOI: 10.1016/j.addr.2021.113973. View

20.

Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O . Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35(4):322-32. DOI: 10.1016/j.ijantimicag.2009.12.011. View